Repare Backer Amplitude Ventures Launches $192M Biotech Fund for Development and Growth

- Amplitude Ventures, a backer of Repare Therapeutics, has unveiled a second biotech fund worth $192 million.
- The fund will be dedicated to the development of innovative biotechnology projects.
- This investment aims to support the growth and advancement of the biotech industry.
- Amplitude Ventures' new fund is a significant step forward in fostering innovation and progress in the field of biotechnology.